Search hospitals > Colorado > Englewood
The Melanoma and Skin Cancer Institute
Claim this profileEnglewood, Colorado 80113
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Melanoma
Conducts research for Adenocarcinoma
54 reported clinical trials
1 medical researcher
Summary
The Melanoma and Skin Cancer Institute is a medical facility located in Englewood, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Melanoma, Adenocarcinoma and other specialties. The Melanoma and Skin Cancer Institute is involved with conducting 54 clinical trials across 195 conditions. There are 1 research doctors associated with this hospital, such as Nicholas DiBella.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 positive
ER positive
Top PIs
Clinical Trials running at The Melanoma and Skin Cancer Institute
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Melanoma
Bladder Cancer
Cancer
Cutaneous Melanoma
Skin Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The Melanoma and Skin Cancer Institute?
The Melanoma and Skin Cancer Institute is a medical facility located in Englewood, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Melanoma, Adenocarcinoma and other specialties. The Melanoma and Skin Cancer Institute is involved with conducting 54 clinical trials across 195 conditions. There are 1 research doctors associated with this hospital, such as Nicholas DiBella.